Vicinitas Therapeutics

Vicinitas Therapeutics is a biotechnology company dedicated to developing a proprietary targeted protein stabilization platform to create new therapies for cancer and genetic diseases. Its vision is to become a leading company in the development of next-generation drugs that impact patients' lives. Our vision is to use our proprietary Deubiquitinase-targeting chimeric molecule (DUBTAC) platform to restore levels of abnormally degraded proteins that cause disease, thereby providing therapeutic benefits.